Sivik Global Healthcare LLC purchased a new position in Bruker Corporation (NASDAQ:BRKR - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 65,000 shares of the medical research company

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Bruker Corporation (NASDAQ:BRKR - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a

Bruker (NasdaqGS:BRKR) and Charité have released a draft atlas of the human plasma proteome at proteoform resolution. The project maps more than 179,000 distinct plasma proteoforms, using Bruker

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

A plasma proteome atlas was disclosed on October 6, 2026. Bruker stock costs EUR 53.90 on October 7,

Bruker stock was trading at USD 63.72 on October 6, 2026, as new proteomics workflows and a UC Berke

Investors need to pay close attention to BRKR stock based on the movements in the options market lately.

Bruker stock was last at USD 63.24 on October 2, 2026, while Guggenheim lifted its target to USD 72